Can changing your vape flavor lower inflammation?
NCT ID NCT05423340
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether switching from banned e-cigarette flavors (like fruit or candy) to a tobacco flavor or using nicotine pouches could reduce signs of inflammation in daily vapers. 163 participants were randomly assigned to one of these options. The goal was to see if these changes could lower health risks associated with vaping.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- E-cigarette flavor (tobacco) and tobacco-free nicotine pouches
- What this could lead to
- If switching to less toxic flavors reduces inflammation, it could point toward safer ways to use nicotine products.
- What could go wrong
- This is a small, completed trial with no long-term follow-up. The results may not apply to all vapers, and switching flavors may not lower health risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
163 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ENDS users as determined by: (a) using banned flavored ENDS with nicotine such as fruit, candy, dessert flavors, and/or any product that indicates such flavors (b) using ENDS daily, regularly for the past 6 months (self-reported). * No smoking tobacco or using smokeless tobacco for the past 6 months. * Subjects should be free of acute respiratory illness within the proceeding 30 days prior to recruitment (self-reported). * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure. * After receiving information regarding the NYS flavor ban individuals must not want to quit vaping or stop using their flavored product for the next 90 days. Exclusion Criteria: * Individuals with health conditions and therapies that may affect immune responses and levels of inflammatory markers, including allergic rhinitis, aspirin/NSAID therapy, asthma, immunodeficiency (HIV or other), Guillain-Barre Syndrome, COPD, or fever/respiratory illness within 30 days prior to entry into study (self-reported). * Pregnant or nursing female participants (self-reported on telephone screener, pregnancy test on Visit#1) * Unable to communicate in English. * Unable or unwilling to follow protocol requirements. * Self-report having active, untreated medical/psychiatric conditions. * History of serious side effects from nicotine or from any nicotine replacement therapies. * Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements * Vulnerable populations, such as cognitively impaired adults, individuals who are not yet adults, pregnant women, and prisoners. * Any condition which in the Investigator's opinion deems the participant an unsuitable candidate to receive study drug. * After receiving information about the NYS flavor ban, participants who report that they are thinking about quitting or stop using their flavor within the next 90 days.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Electronic cigarette use are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14206, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A text at the right moment: can it defuse Stress-Led cravings?
- Can E-Cigs help methadone patients kick tobacco?
- Teens see vape labels: will warnings work?
- ER smokers get E-Cig kits in bold Quit-Smoking trial
- Cannabis compound may change how you vape
- E-Cig flavor showdown: do menthol and tobacco hook smokers differently?